Respiratory exercise device
Description
The broken lines that are immediately adjacent to the claimed areas depict the bounds of the claimed design while all other broken lines are directed to environment. The broken lines form no part of the claimed design.
Claims
The ornamental design for a respiratory exercise device, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
D303440 | September 12, 1989 | Campbell |
7721729 | May 25, 2010 | Von Hollen |
D713531 | September 16, 2014 | Way |
D731050 | June 2, 2015 | Meyer |
D760889 | July 5, 2016 | Evans |
D778429 | February 7, 2017 | Engelbreth |
D780249 | February 28, 2017 | Ramsthaler |
D795431 | August 22, 2017 | Way |
D795440 | August 22, 2017 | Way |
20030234017 | December 25, 2003 | Pelerossi et al. |
20080078383 | April 3, 2008 | Richards |
20130273490 | October 17, 2013 | Way |
20140150790 | June 5, 2014 | Meyer |
20160038056 | February 11, 2016 | Johnson et al. |
20160150998 | June 2, 2016 | Shiner et al. |
20180228643 | August 16, 2018 | Goldstein |
2948137 | November 2015 | CA |
WO-2004012577 | February 2004 | WO |
2015120435 | August 2015 | WO |
- Hammacher Schlemmer. Link: https://www.hammacher.com/product/respiratory-exerciser?cm_cat=ProductSEM&cm_pla=AdWordsPLA&source=PRODSEM&gclid=EAlalQobChMlz9Swsaeb4AlVy4CfCh1pPA64EAQYBCABEglQJPD_BwE. Visited Feb. 1, 2019. The Respiratory Exerciser. (Year: 2019).
- Abe Fumito, et al., Histone deacetylase inhibitors inhibit metastasis by restoring tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma, Oncotarget, vol. 8, No. 5, pp. 7572-7585, 2017.
- Lindahl Lisa M., et al., Prognostic miRNA classifier in early-stage mycosis fungoides: Development and validation in a Danish nationwide study, Blood, published by the American Society of Hematology, Prepublished online Dec. 5, 2017, DOI: 10.1182/blood-2017-06-788950.
- Marosvari Dora., et al., Altered MicroRNA Expression in Folliculotropic and Transformed Mycosis Fungoides, Springer-Pathol. Oncol. Res., 21:821-825, 2015.
- Narducci MG., et al., MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome, Cell Death and Disease, 2, e151; Mcmillan Publishers Limited, 2011.
- Ralfkiaer Ulrik., et al., MicroRNA Expression in Early Mycosis Fungoides Is Distinctly Different from Atopic Dermatitis and Advanced Cutaneous T-Cell Lymphoma, Anticancer Research, 34:7207-7218, 2014.
- Sandoval Juan, et al., MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated MicroRNA in Cutaneous T-Cell Lymphpma, Journal of Investigative Dermatology, 2015, 135, 1128-1137, The Society of Investigative Dermatology, 2015.
Patent History
Patent number: D874006
Type: Grant
Filed: Dec 15, 2017
Date of Patent: Jan 28, 2020
Assignee: Aerofit.dk ApS (Birkerød)
Inventors: Christian Tulberg Poulsen (Birkerød), Tue Toft (Københaven N)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Lauren D McVey
Application Number: 29/629,852
Type: Grant
Filed: Dec 15, 2017
Date of Patent: Jan 28, 2020
Assignee: Aerofit.dk ApS (Birkerød)
Inventors: Christian Tulberg Poulsen (Birkerød), Tue Toft (Københaven N)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Lauren D McVey
Application Number: 29/629,852
Classifications
Current U.S. Class:
Pulmonary (38) (D24/164)